Wedbush Upgrades ZymoGenetics (ZGEN) to Outperform; Believe ZGEN on Track to Meet 2010 Sales Estimates
Tweet Send to a Friend
Wedbush upgrades ZymoGenetics, Inc. (Nasdaq: ZGEN) from Neutral to Outperform.
Wedbush analyst says, "RECOTHROM Q3/Q4 sales growth was 42%, which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "RECOTHROM Q3/Q4 sales growth was 42%, which ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
